Search results for " industry" in Articles / App Notes
Article
Cytiva Introduces the Xcellerex Automated Perfusion System
“Along with our end-to-end flexible manufacturing solutions, automation technology, and trusted expertise, we have introduced Xcellerex APS to support the industry’s journey to integrated continuous m…
Article
Platform for Purification of VHH-type Antibody Fragments
Click here to read this poster >>
Protein A affinity chromatography resins have been used to purify monoclonal antibodies (mAbs) by the bioprocess industry at all scales for a long time. Howev…
Article
Preparing for the Future Visions and Insights for Biomanufacturing
Click here to learn more >>
The biopharmaceutical industry has a reputation of being averse to change. Yet, new market dynamics, such as growing competition from biosimilars and niche drugs targe…
Article
Oligonucleotide Therapeutics Heading for Tons of Quantity in Annual Supply Need
Click here to read the full article >>
Solid-phase flow through technology poised to annually produce metric tons (1000 kg) provides the oligonucleotide therapeutic industry efficient synthesis t…
Article
Considerations for Optimizing Process Development
Click here to read the article >>
Intensify your cell culture processes to keep pace with today’s industry and regulatory expectations.
Article
Improving mAb Manufacturing Productivity by Optimizing Buffer and Media Prep Process Flow
BioPhorum Operations Group, “An Economic Evaluation of Buffer Preparation Philosophies for the Biopharmaceutical Industry,” BioPhorum.com, December 2019.
2. N. Deorkar, “Enhancing Cleanroom QC…
Article
Pairing Data Connectivity and Comprehensive Automation
In the biopharma industry, process data are used in many ways throughout process development and the different production phases. Learn more about Cytiva’s automation solutions for bioprocessing, ce…
Article
Production of Recombinant Adeno-associated Virus Vectors Using Microcarrier Culture of HEK293T Cells
As of March 2020, more than 4310 gene therapy clinical trials have been performed worldwide, with only 518 of them in Phase III and Phase IV. As the gene therapy projects enter clinical Phase III or g…
Article
Eliminating Residual Impurities Starts with a Strategic Plan
The availability of and reference to industry white papers might be convincing, he says. As an example, he points to the BioPhorum Operations Group (BPOG) and its guide for the assessment of leachable…
Article
The Importance of Partnering for Bioanalytical Studies
FDA, Bioanalytical Method Validation Guidance for Industry] (CDER, May 2018).
3. ICH, M10 Bioanalytical Method Validation, draft version (Feb. 26, 2019).